United States
Jackpot! California cannabis commission releases report today
Submitted by Anonymous on Wed, 2010-02-17 23:35- Antiemetics
- California
- Cannabis
- Decriminalization of non-medical cannabis in the United States
- Effects of cannabis
- FDA
- Health
- Healthcare in the United States
- http://www.cmcr.ucsd.edu/
- http://www.cmcr.ucsd.edu/CMCR_REPORT_FEB17.pdf
- Legality of cannabis
- Medical cannabis
- Medicinal plants
- Medicine
- Neuropathy
- Other
- Psychedelics, dissociatives and deliriants
- United States
- University of California
- University of California
The Center for Cannabis Research at the University of California has weighed in today with a report on original scientific research on the therapeutic value of marijuana or cannabis. The Center was created to advise the California Legislature about marijuana.
I have long thought that the principal problem with medical marijuana is that it kind of exists in an "evidence-free" zone. The publication of this document summarizing multiple different clinical research studies on medical marijuana.
- Read more
- 1739 reads
Overactive marketing of drugs for overactive bladder
Submitted by Anonymous on Tue, 2010-02-09 13:19
- Read more
- 1432 reads
FDA cracks down on therapeutic ozone devices
Submitted by Anonymous on Mon, 2010-02-01 12:10- AIDS
- Applied Ozone Systems
- Auburn
- Barbara Duck
- California
- cancer
- catheter
- Chemistry
- Company Location
- diabetic foot
- diseases
- FDA
- Food and Drug Administration
- foot ulcers
- Health
- Health
- hepatitis
- herpes
- hyperbaric oxygen therapy
- infection
- Labor
- Labor
- Maryland
- Medical device
- Medicine
- Ozone
- Ozone therapy
- SILVER SPRING
- Social Issues
- Social Issues
- the Cochrane Review
- U.S. Food and Drug Administration
- United States
- USD
I have had people take hyperbaric oxygen therapy for foot ulcers with some success, but otherwise had no idea these things were being used to treat cancer, AIDS, and other illnesses. The Cochrane Review looks to be gearing up to review the use of ozone in diabetic foot ulcers soon, stay tuned for some of their usually definitive coverage.
Doctors purveying questionable therapies: if you're not careful, the FDA will sic the US Marshals on you!
- Read more
- 1614 reads
Terms and Conditions of Use InteractMD.com
Submitted by Anonymous on Wed, 2009-04-22 19:18By using this site you signify that you have read and assent to these Terms and Conditions of Use. If you do not agree to follow all of the Terms and Conditions of Use do not use this site. InteractMD.com (InteractMD.com) reserves the right to update these Terms and Conditions of Use at any time. Your continued use of the InteractMD.com website means that you accept those changes. This site does not provide medical advice.
- Read more
- 1409 reads
Novel Hsp90 Inhibitor to Begin Phase 1 Study in Cancer Patients
Submitted by Anonymous on Wed, 2009-04-08 17:22- Adrian Hobden
- apoptosis
- Azixa
- breast cancer
- Cancer
- cancer
- Cancer Treatment
- cancers
- chemical
- Clinical trial
- colon cancer
- Company Affiliates
- Company Ticker
- disease
- drug development
- Drug discovery
- FDA
- FDAPhase
- finance
- gastric cancer
- gastric cancers
- glioblastoma
- Health
- Health
- healthcare
- HIV
- Hsp90
- Hsp90
- Labor
- Labor
- lung cancer
- manufacturing
- Medicine
- melanoma
- metastasis
- MPC-3100
- MPC-4326
- multiple myeloma
- myeloid leukemia
- Myriad Genetics Inc.
- Myriad Pharmaceutical
- Myriad Pharmaceuticals Inc.
- Myriad Pharmaceuticals’ Development Programs Myriad Pharmaceuticals
- Occupational safety and health
- Pathology
- pharmacokinetics
- President
- Private
- Prostate cancer
- prostate cancer
- Salt Lake City
- Securities and Exchange Commission
- Social Issues
- Social Issues
- Technology
- Technology
- TopoTarget
- treatment of a wide range of cancers
- treatment of cancer
- treatment of HIV
- treatment of primary glioblastoma and melanoma
- tumor
- United States
- www.myriad.com
Salt Lake City April 8 2009 -- Myriad Pharmaceuticals Inc. announced today that the FDA has approved an Investigational New Drug (IND) application to begin a Phase 1 clinical study with its Hsp90 inhibitor MPC-3100 for the treatment of cancer. The clinical development plan for MPC-3100 is designed to expedite the drug candidate through the clinical development path. The Phase 1 trial will assess the safety and pharmacokinetics profile of MPC-3100.
- Read more
- 1957 reads
Thyroid cancer: a review
Submitted by Anonymous on Tue, 2009-01-20 17:59- Advocate
- Anaplastic thyroid cancer
- author
- Cancer Treatment
- chemotherapy
- energy
- Follicular thyroid cancer
- Goitre
- Graves' disease
- http://www.cancer.gov/cancertopics/types/thyroid
- http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_thyroid_can...
- Hyperthyroidism
- imaging
- Medicine
- Medullary thyroid cancer
- MRI
- National Cancer Institute
- Oncology
- Otolaryngology
- PET
- physician
- radiation
- RAI
- Social Issues
- Social Issues
- surgeon
- surgeon for best results
- Thyroid disease
- Thyroid neoplasm
- Thyroidectomy
- treatment of thyroid cancer
- treatment of thyroid lymphoma
- ultrasound
- United States
Where is the thyroid gland and what is it’s function? The thyroid gland is shaped like a butterfly and sits just below the voice box and in front of the trachea (wind-pipe). It resides under thin muscle layers in the midline central neck just above the sternum and moves with swallowing as it is attached to the trachea. The thyroid gland is a central organ in the body that secretes thyroid hormones and as such regulates our body’s metabolism energy level and various other functions.
- Read more
- 2992 reads
Leukemia drug shows activity--for MS!
Submitted by Anonymous on Tue, 2008-12-30 19:24- Advocate
- Alemtuzumab
- Autoimmune diseases
- Biology
- Clinical Neurosciences University of Cambridge
- Cytokines
- Immune system
- Interferon
- Interferon beta-1a
- lecturer
- Medicine
- Monoclonal antibodies
- Multiple sclerosis
- Neurological disorders
- New England Journal
- Other
- the New England Journal of Medicine
- treatment of MS
- Treatment of multiple sclerosis
- United States
Multiple sclerosis (MS) is the most common neurological disorder which affects the brain and spinal cord of generally young persons. Majority of researchers consider it as an "autoimmune disease” in which white blood cells intend to fight infection or disease are mistaken to target and attack the body's own cells. MS affects almost 400 000 people in the United States and quite a few million worldwide. Many useful medications are available for the treatment of MS.
- Read more
- 1212 reads
Rituximab shows efficacy in rheumatoid arthritis in randomized trials
Submitted by Anonymous on Sun, 2008-12-28 10:40Rheumatoid arthritis (RA) is an agonizing autoimmune disorder of uncertain origin leading to chronic inflammation at the joints. RA develops in three stages. Nearly 46 million Americans or more than 21 percent of the adult population are affected by this disorder. The origin of RA is unknown but the disease can be controlled by way of new drugs exercise joint protection skills and self-management techniques.
- Read more
- 1234 reads
Coronary CT fares well compared with conventional angiography in NEJM article
Submitted by Anonymous on Wed, 2008-12-24 18:47- American College of Cardiology
- Angiography
- author
- Baltimore
- Canada
- cardiologist
- Cardiology
- Cardiovascular diseases
- Coronary artery disease
- director
- General Electric Co.
- imaging
- Johns Hopkins University
- Julie Miller
- Matthew Budoff
- Medical imaging
- Medicare
- Medicine
- New England Journal
- Other
- Private
- Radiography
- Radiology
- the American College
- The Netherlands
- the New England Journal of Medicine
- Toshiba Medical Systems
- UCLA
- UCLA Medical Center
- United States
- X-ray computed tomography
According to American Heart Association more than 1.2 million patients in the U.S. go through cardiac angiograms every year and out of which 1 to 2% of cases results in complications and nearly 25 people die every year with this process. A new study published in the New England Journal of Medicine (NEJM) however has revealed that noninvasive CT scans are almost as precise at imaging coronary artery blockages as against traditional angiography and are much safer for the patients.
- Read more
- 1426 reads
Diabetes drugs implicated in bone fracture risk
Submitted by Anonymous on Sat, 2008-12-13 08:19- Actos
- Anti-diabetic drugs
- author
- Avandia
- Black box warning
- Diabetes
- Diabetes mellitus
- Diabetes mellitus type 2
- FDA
- GlaxoSmithKline
- GlaxoSmithKline
- Health
- lecturer
- Lorraine Lipscombe
- Medicine
- Other
- Person Career
- Pioglitazone
- Pyridines
- researcher
- Reuters
- Rosiglitazone
- rosiglitazone
- the Canadian Medical Association Journal
- Thiazolidinediones
- United States
- University of East Anglia
- University of East Anglia in Norwich
- University of Toronto
- University of Toronto in Canada
- Wake Forest University
- Yoon Loke
A new study published in the December 10 online issue of the Canadian Medical Association Journal reports that continued use of well known oral diabetes GlaxoSmithKline's drugs Avandia (rosiglitazone) and Actos (pioglitazone) almost doubles the risk of bone fractures in women with type 2 diabetes. Researchers had been aware that two thiazolidinedione (TZD) drugs for diabetes were correlated with fractures but the scope of the risk was not known. That is the reason why a study was constituted to know the efficacy of the diabetes drug. The lead researcher Dr.
- Read more
- 1409 reads